Liu S - Search Results

1

Clinical application of ¹⁸F-FCH PET/CT in the diagnosis and treatment of hyperparathyroidism.

Liu S, Li M, Pang H, Zuo R, Kong L, Wang Z, Li W, Xia Z, Wang D, Xu L. Liu S, et al. Front Endocrinol (Lausanne). 2023 Apr 11;14:1100056. doi: 10.3389/fendo.2023.1100056. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37113486 Free PMC article.

2

Associations of whole-body 18F-FDG PET/CT parameters and SCC-Ag level with overall survival in patients with cervical cancer.

Guan L, Zuo R, Wang Z, Xu L, Liu S, Pang H. Guan L, et al. Among authors: liu s. Nucl Med Commun. 2022 Jan 1;43(1):49-55. doi: 10.1097/MNM.0000000000001493. Nucl Med Commun. 2022. PMID: 34887369

3

A semiquantitative study of the optimal whole-body imaging time after ¹³¹I therapy for differentiated thyroid cancer.

Liu S, Zuo R, Yang T, Pang H, Wang Z. Liu S, et al. Front Endocrinol (Lausanne). 2022 Aug 25;13:955387. doi: 10.3389/fendo.2022.955387. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36093082 Free PMC article.

4

Prognostic role of pretreatment ¹⁸F-FDG PET/CT and hematological parameters in relapsed/refractory Hodgkin lymphoma patients treated with immune checkpoint inhibitors and chemotherapy: a dual-center cohort study.

Yang T, Liu S, Zuo R, Liang H, Xu L, Wang Z, Chen X, Pang H. Yang T, et al. Among authors: liu s. BMC Med Imaging. 2023 Jan 21;23(1):12. doi: 10.1186/s12880-023-00967-x. BMC Med Imaging. 2023. PMID: 36681824 Free PMC article.

5

The value of Gallium-68 prostate-specific membrane antigen ([⁶⁸Ga]Ga-PSMA-11) PET/CT and 2-[¹⁸F]fluoro-2-deoxy-D-glucose (2-[¹⁸F]FDG) PET/CT in the detection of thyroid cancer lesions: a prospective head-to-head comparison.

Shi Y, Feng Y, Xu L, Li W, Guan L, Zuo R, Liu S, Pang H, Wang Z. Shi Y, et al. Among authors: liu s. Br J Radiol. 2023 Jul 2:20230291. doi: 10.1259/bjr.20230291. Online ahead of print. Br J Radiol. 2023. PMID: 37393530

6

Key to the Treatment of Primary Aldosteronism in Secondary Hypertension: Subtype Diagnosis.

Zuo R, Liu S, Xu L, Pang H. Zuo R, et al. Among authors: liu s. Curr Hypertens Rep. 2023 Dec;25(12):471-480. doi: 10.1007/s11906-023-01269-x. Epub 2023 Oct 3. Curr Hypertens Rep. 2023. PMID: 37787864 Review.

7

The value of gallium-68 prostate-specific membrane antigen PET/CT and 2-[18F]fluoro-2-deoxy-D-glucose PET/CT in the detection of thyroid cancer lesions: a prospective head-to-head comparison.

Shi Y, Feng Y, Xu L, Li W, Guan L, Zuo R, Liu S, Pang H, Wang Z. Shi Y, et al. Among authors: liu s. Br J Radiol. 2023 Jul 2:bjr.20230291. doi: 10.1259/bjr.20230291. Online ahead of print. Br J Radiol. 2023. PMID: 38904463

8

Clinical value of ⁶⁸Ga-pentixafor PET/CT in patients with primary aldosteronism and bilateral lesions: preliminary results of a single-centre study.

Zuo R, Liu S, Li W, Xia Z, Xu L, Pang H. Zuo R, et al. Among authors: liu s. EJNMMI Res. 2024 Jul 4;14(1):61. doi: 10.1186/s13550-024-01125-2. EJNMMI Res. 2024. PMID: 38965078 Free PMC article.

9

Typing diagnostic value of ⁶⁸Ga-pentixafor PET/CT for patients with primary aldosteronism and unilateral nodules.

Zuo R, Liu S, Ren X, Li W, Xia Z, Xu L, Pang H. Zuo R, et al. Among authors: liu s. Endocrine. 2024 Sep 9. doi: 10.1007/s12020-024-04024-7. Online ahead of print. Endocrine. 2024. PMID: 39251468

10

Dopamine transporter availability based on white matter hyperintensity during early to mid-stage Parkinson's disease and multiple system atrophy: a case control study.

Zuo R, Liu S, Li W, Xia Z, Xu L, Pang H. Zuo R, et al. Among authors: liu s. Neurol Sci. 2024 Oct 30. doi: 10.1007/s10072-024-07856-3. Online ahead of print. Neurol Sci. 2024. PMID: 39476088

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

77,938 results

Search Page

Filters